Opus Genetics, Inc. Operating Leases, Future Minimum Payments Due, Next Twelve Months
Opus Genetics, Inc. (IRD) had Operating Leases, Future Minimum Payments Due, Next Twelve Months of $176.08 thousand as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent · last filed 2019-03-07
- 2018-12-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $176.08K.
- 2018-09-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $70.81K.
- 2018-06-30: Operating Leases, Future Minimum Payments Due, Next Twelve Months $141.39K.
- 2018-03-31: Operating Leases, Future Minimum Payments Due, Next Twelve Months $210.33K.
| Period end | Operating Leases, Future Minimum Payments Due, Next Twelve Months |
|---|---|
| 2018-12-31 | $176.08K 10-K · filed 2019-03-07 |
| 2018-09-30 | $70.81K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $141.39K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $210.33K 10-Q · filed 2018-05-04 |
| 2017-12-31 | $279.27K 10-K · filed 2018-03-09 |
| 2017-09-30 | $68.94K 10-Q · filed 2017-11-03 |
| 2017-06-30 | $137.36K 10-Q · filed 2017-08-04 |
| 2017-03-31 | $189.06K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $255.73K 10-K · filed 2017-02-24 |
| 2016-09-30 | $66.67K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $134.26K 10-Q · filed 2016-08-05 |
| 2016-03-31 | $203.12K 10-Q · filed 2016-05-06 |
| 2015-12-31 | $269.73K 10-K · filed 2016-03-14 |
| 2015-09-30 | $66.61K 10-Q · filed 2015-11-02 |
| 2015-06-30 | $133.04K 10-Q · filed 2015-08-07 |
| 2014-09-30 | $50.06K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $77.04K 10-Q · filed 2014-08-13 |
| 2014-03-31 | $114.62K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $139.68K 10-K · filed 2014-03-21 |
| 2013-09-30 | $18.79K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $37.58K 10-Q · filed 2013-08-12 |
| 2012-09-30 | $40.20K 10-Q · filed 2012-11-08 |
| 2012-06-30 | $80.40K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |